These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 13635459)

  • 1. Control of free tumor cell growth by topical chemotherapeutic agents.
    THOMAS CG; WEEKS PM; BROWN BC
    Surg Forum; 1958; 9():598-603. PubMed ID: 13635459
    [No Abstract]   [Full Text] [Related]  

  • 2. A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models.
    Emanuel S; Gruninger RH; Fuentes-Pesquera A; Connolly PJ; Seamon JA; Hazel S; Tominovich R; Hollister B; Napier C; D'Andrea MR; Reuman M; Bignan G; Tuman R; Johnson D; Moffatt D; Batchelor M; Foley A; O'Connell J; Allen R; Perry M; Jolliffe L; Middleton SA
    Mol Pharmacol; 2004 Sep; 66(3):635-47. PubMed ID: 15322256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs.
    Singh V; Singh SM
    Anticancer Drugs; 2007 Nov; 18(10):1123-32. PubMed ID: 17893512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotides.
    van der Most RG; Himbeck R; Aarons S; Carter SJ; Larma I; Robinson C; Currie A; Lake RA
    J Immunother; 2006; 29(2):134-42. PubMed ID: 16531814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of chemotherapeutic preparations on the growth of heterotransplanted tumors in man].
    GARIN AM
    Vopr Onkol; 1960; 6(9)():25-30. PubMed ID: 13703670
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the chemopreventive and chemotherapeutic effects of topical and oral retinoids for both cutaneous and internal neoplasms.
    Khera P; Koo JY
    J Drugs Dermatol; 2005; 4(4):432-46. PubMed ID: 16004016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapeutic agents potentiate adenoviral gene therapy for pancreatic cancer.
    Egami T; Ohuchida K; Miyoshi K; Mizumoto K; Onimaru M; Toma H; Sato N; Matsumoto K; Tanaka M
    Cancer Sci; 2009 Apr; 100(4):722-9. PubMed ID: 19302285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine inhibition of chemotherapy response in human liver tumor cells by insulin-like growth factor-II.
    Lund P; Schubert D; Niketeghad F; Schirmacher P
    Cancer Lett; 2004 Mar; 206(1):85-96. PubMed ID: 15019164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlated changes and value of redox-status, nitric oxide and blood supply in experimental malignant tumor growth].
    Kipiani V; Bejitashvili N; Gambashidze K; Sanikidze T
    Georgian Med News; 2007 Nov; (152):48-51. PubMed ID: 18175835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y; Yang L; Zhao X; Su JM; Hu B; Liu JY; Niu T; Luo Y; Li Q; Wei YQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):557-61. PubMed ID: 15583981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bioflavonoids as potential chemotherapeutic agents.
    Womack K; Anderson M; Tucci M; Hamadain E; Benghuzzi H
    Biomed Sci Instrum; 2006; 42():464-9. PubMed ID: 16817652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
    Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
    Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SRC uses Cas to suppress Fhl1 in order to promote nonanchored growth and migration of tumor cells.
    Shen Y; Jia Z; Nagele RG; Ichikawa H; Goldberg GS
    Cancer Res; 2006 Feb; 66(3):1543-52. PubMed ID: 16452211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of malignant cell growth and spread by combined internal (topical) and external (systemic) irradiations.
    GOLDIE H; TARLETON GJ; STRONG O; DEADERICK LD
    Cancer Res; 1960 Oct; 20():1324-8. PubMed ID: 13706522
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
    Kirchmair R; Walter DH; Ii M; Rittig K; Tietz AB; Murayama T; Emanueli C; Silver M; Wecker A; Amant C; Schratzberger P; Yoon YS; Weber A; Panagiotou E; Rosen KM; Bahlmann FH; Adelman LS; Weinberg DH; Ropper AH; Isner JM; Losordo DW
    Circulation; 2005 May; 111(20):2662-70. PubMed ID: 15897348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pasteurella pneumotropica produces regression of human tumors transplanted in immunodeficiency mice].
    Carriquiriborde M; Milocco SN; Principi G; Cagliada P; Carbone C
    Medicina (B Aires); 2006; 66(3):242-4. PubMed ID: 16871912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular-targeting therapies for treatment of malignant disease.
    Siemann DW; Chaplin DJ; Horsman MR
    Cancer; 2004 Jun; 100(12):2491-9. PubMed ID: 15197790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.
    Gee MS; Makonnen S; al-Kofahi K; Roysam B; Payvandi F; Man HW; Muller GW; Lee WM
    Cancer Res; 2003 Dec; 63(23):8073-8. PubMed ID: 14678955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.